Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Vistagen Therapeutics (VTGN) over the last 12 years, with Q4 2025 value amounting to $1.5 million.

  • Vistagen Therapeutics' Prepaid Assets rose 680.67% to $1.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 million, marking a year-over-year increase of 680.67%. This contributed to the annual value of $1.6 million for FY2025, which is 584.33% up from last year.
  • Latest data reveals that Vistagen Therapeutics reported Prepaid Assets of $1.5 million as of Q4 2025, which was up 680.67% from $1.8 million recorded in Q3 2025.
  • Vistagen Therapeutics' Prepaid Assets' 5-year high stood at $3.5 million during Q2 2025, with a 5-year trough of $802000.0 in Q1 2023.
  • Its 5-year average for Prepaid Assets is $1.9 million, with a median of $1.7 million in 2025.
  • Per our database at Business Quant, Vistagen Therapeutics' Prepaid Assets surged by 48740.4% in 2021 and then crashed by 7079.18% in 2023.
  • Vistagen Therapeutics' Prepaid Assets (Quarter) stood at $2.9 million in 2021, then plummeted by 67.54% to $953200.0 in 2022, then surged by 55.3% to $1.5 million in 2023, then decreased by 6.71% to $1.4 million in 2024, then grew by 6.81% to $1.5 million in 2025.
  • Its Prepaid Assets was $1.5 million in Q4 2025, compared to $1.8 million in Q3 2025 and $3.5 million in Q2 2025.